Agenda Details | ASGCT Annual Meeting

Detailed Program

Tuesday, May 07 2024
08:00 AM – 12:00 PM ET
Ballroom 1

Delivery & Development of Precision Genome Editing Technologies

In this workshop, we will focus on the intersection between the engineering, delivery, and in vivo application of genome editing tools. We will discuss how novel delivery research drives innovation and need for new genome editing strategies, and vice versa. Attendees of this workshop can hope to learn about the most recent applications of a variety of genome editors across a broad range of target cell and organ systems.

Session Details

08:00 AM - 12:00 PM - Ballroom 1

Holly Rees - Beam Therapeutics

Co-Chair

08:00 AM - 12:00 PM - Ballroom 1

Julian Grünewald - MD - Technical University of Munich

Co-Chair

08:05 AM - 08:28 AM - Ballroom 1

Christian Kupatt - TUM

In vivo gene editing in porcine models of heart disease, also in comparison to “classic” AAV gene therapy

08:28 AM - 08:51 AM - Ballroom 1

Samuele Ferrari - PhD - SR-TIGET

Leveraging on the LNP/mRNA technology for ex-vivo gene editing

08:51 AM - 09:14 AM - Ballroom 1

Y. Esther Tak - PhD - MGH

Next generation epigenetic editing

09:14 AM - 09:37 AM - Ballroom 1

Samagya Banskota - PhD - Boston University

In vivo gene editing with virus-like particles

09:37 AM - 10:00 AM - Ballroom 1

James Dahlman - PhD - Georgia Tech

LNP development and screening

10:00 AM - 10:23 AM - Ballroom 1

Jonathan Levy - Prime Medicine

Development and delivery of prime editors

10:23 AM - 10:46 AM - Ballroom 1

Amy Wagers - Harvard University

In vivo AAV delivery for genome editing

10:46 AM - 11:09 AM - Ballroom 1

Makoto Saito - MIT/Broad Institute

Fanzor is a eukaryotic programmable RNA-guided endonuclease

11:05 AM - 11:25 AM - Ballroom 1

Basem Al-Shayeb -

Programmable multi-kilobase RNA editing using CRISPR-mediated trans-splicing

11:09 AM - 11:32 AM - Ballroom 1

Cameron Glasscock - University of Washington

Session Details

Detailed Program

Delivery & Development of Precision Genome Editing Technologies

Session Details

Co-Chair

Co-Chair

In vivo gene editing in porcine models of heart disease, also in comparison to “classic” AAV gene therapy

Leveraging on the LNP/mRNA technology for ex-vivo gene editing

Next generation epigenetic editing

In vivo gene editing with virus-like particles

LNP development and screening

Development and delivery of prime editors

In vivo AAV delivery for genome editing

Fanzor is a eukaryotic programmable RNA-guided endonuclease

Programmable multi-kilobase RNA editing using CRISPR-mediated trans-splicing

Computational design of sequence-specific DNA-binding proteins